Also from this source

You just read:

New Data for DARZALEX® (daratumumab) Presented at ASH 2017 Showed Feasibility of Subcutaneous Use and Promise of DARZALEX as a Treatment for Smoldering Multiple Myeloma

News provided by

Janssen Biotech, Inc.

Dec 11, 2017, 16:15 EST